Spatial Control of Myeloid Differentiation
骨髓分化的空间控制
基本信息
- 批准号:10671625
- 负责人:
- 金额:$ 51.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Myelocytic LeukemiaAdoptive TransferAnatomyBone MarrowCSF1 geneCSF3 geneCellsCessation of lifeCuesDNMT3aDataDendritic CellsDevelopmentDiscontinuous CapillaryDiseaseDistalEmergency SituationEndothelial CellsEndotheliumErythroidErythropoiesisFLT3 geneFLT3 ligandFailureHematopoiesisHematopoieticHomeostasisImageIn SituLocationMLL-AF9MacrophageMacrophage Colony-Stimulating FactorManuscriptsMapsModelingMolecularMusMyelogenousMyelopoiesisNormal CellOutputPathologyPericytesPhysiologyProductionReporterRoleSchemeSignal TransductionSourceStressStructureTestingTherapeutic Interventioncytokinecytopeniaexperimental analysisexperimental studygranulocytein vivoin vivo Modelleukemialeukemia initiating cellmonocytemortalitymouse geneticsneutrophilnovelprogenitorrecruitsegregationspatiotemporalstem cellstooltranscriptomics
项目摘要
Abstract:
Mounting evidence indicates that lineage decisions are controlled by local structures that support differentiation
in distinct regions of the bone marrow. Our ability to manipulate hematopoiesis to treat disease has been
hampered by our lack of understanding of these anatomical cues.
We have found that HPC are regionally organized in the BM and that progenitors and immature cells belonging
to the same lineage segregate to different sinusoids. We have also found that there is regional organization to
CSF1 production and that specific BM vessels are critical sources of CSF1 that regulate MDP, monocytes and
dendritic cells but not HSC or macrophages. The central hypothesis is that different subsets of sinusoids
function as assembly lines or hubs that organize and maintain different hematopoietic lineages through the
production of lineage-specific cytokines. We want to understand how these cellular assembly lines function in
the steady-state and after perturbation by acute myeloid leukemia (AML).
We will test this hypothesis in two aims. In Aim 1 we will determine the physiology of these assembly lines
using clonal fate mapping in situ; identifying the components of each assembly line; and conditionally deleting
specific cytokines from key components of each assembly line. In Aim 2 we will investigate how AML inhibits
normal hematopoiesis by perturbing the microenvironment that supports each assembly line.
抽象的:
越来越多的证据表明,血统决定是由支持分化的当地结构控制的
位于骨髓的不同区域。我们操纵造血来治疗疾病的能力已经
由于我们对这些解剖线索缺乏了解而受到阻碍。
我们发现 HPC 在 BM 中按区域组织,祖细胞和未成熟细胞属于
同一谱系分离到不同的正弦曲线。我们还发现有一个区域组织
CSF1 的产生以及特定的 BM 血管是调节 MDP、单核细胞和
树突状细胞,但不是 HSC 或巨噬细胞。中心假设是正弦曲线的不同子集
作为装配线或枢纽,通过组织和维持不同的造血谱系
谱系特异性细胞因子的产生。我们想了解这些细胞装配线如何在
稳态和急性髓系白血病(AML)扰动后。
我们将从两个目标来检验这个假设。在目标 1 中,我们将确定这些装配线的生理学
使用原位克隆命运图谱;识别每条装配线的组件;并有条件删除
来自每条装配线关键部件的特定细胞因子。在目标 2 中,我们将研究 AML 如何抑制
通过扰乱支持每条装配线的微环境来维持正常的造血功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Lucas其他文献
Daniel Lucas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Lucas', 18)}}的其他基金
Hematopoietic Stem Cell engraftment in the injured niche
造血干细胞植入受伤的生态位
- 批准号:
10581667 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Hematopoietic Stem Cell engraftment in the injured niche
造血干细胞植入受伤的生态位
- 批准号:
10413317 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Role of the local vascular microenvironment in the bone marrow response to inflammation
局部血管微环境在骨髓炎症反应中的作用
- 批准号:
10273567 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
Role of the local vascular microenvironment in the bone marrow response to inflammation
局部血管微环境在骨髓炎症反应中的作用
- 批准号:
10451791 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
Role of the local vascular microenvironment in the bone marrow response to inflammation
局部血管微环境在骨髓炎症反应中的作用
- 批准号:
10624343 - 财政年份:2021
- 资助金额:
$ 51.23万 - 项目类别:
Cellular crosstalk in the hematopoietic microenvironment
造血微环境中的细胞串扰
- 批准号:
9921466 - 财政年份:2018
- 资助金额:
$ 51.23万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 51.23万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 51.23万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 51.23万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 51.23万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 51.23万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 51.23万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 51.23万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 51.23万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 51.23万 - 项目类别: